跳转至内容
Merck
CN

54805

Sigma-Aldrich

Disposable PD-10 Desalting Column

登录查看公司和协议定价

选择尺寸


关于此项目

UNSPSC代码:
13111000
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

物料

polypropylene (with polyethylene frit)

包装

pkg of 30 ea

储存温度

2-8°C

一般描述

The PD-10 desalting columns contain Sephadex® G-25 for gel filtration (size exclusion) of biomolecules. Globular compounds pass quickly through the column. Compounds, such as salts, pass through the column slowly. The column actually separates two classes of compounds by their molecular weight, thus desalting the protein of interest.

应用

Disposable PD-10 Desalting Column has been used:
  • to concentrate samples of high peroxidase activity from a PGF-HRP (prostaglandin F2α-horse radish peroxidase) conjugate solution and to remove free PGF from this solution.
  • for the separation of lanthanide-labeled proteins from unbound lanthanides by column chromatography.
  • for repurification of protein by removal of lower molecular weight fragments after elution from Ni-NTA agarose affinity column.
  • for separation of Eu-labeled protein from free Eu (Europium).
PD-10 desalting columns have been used to purify reduced Alemtuzumab (Campath, Berlex) humanized IgG1 rat monoclonal antibody from excess phospine, which is being developed for the treatment of chronic lymphocytic leukemia, autoimmune disease and for the prevention of transplant rejection.

法律信息

Sephadex is a registered trademark of Cytiva

象形图

Exclamation markEnvironment

警示用语:

Warning

危险声明

危险分类

Aquatic Chronic 2 - Skin Sens. 1

储存分类代码

10 - Combustible liquids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

U Seitz et al.
European journal of nuclear medicine, 26(10), 1265-1273 (1999-12-14)
Anti-NCA antigen antibody BW 250/183 (Anti-Granulocyte) localizes more than 50% of injected antibody dose to the bone marrow. Therefore, this antibody is promising for adjuvant conditioning radioimmunotherapy of bone marrow before bone marrow transplantation. To examine its potential use for
Hemanta K Shrestha et al.
Biology of reproduction, 87(1), 18-18 (2012-05-04)
Horses are about five times more sensitive to the luteolytic effect of prostaglandin F2alpha (PGF) than cattle, as indicated by a recommended clinical dose of 5 mg in horses and 25 mg in cattle. Novel evaluations of the PGF plasma
Large-Scale Production of Highly Active Recombinant Omi from Escherichia coli Expressed Soluble Protein Aggregates.
Rahman M, et al.
Biomedical Research, 23, 183-190 (2012)
Christophe M M Lahorte et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45(6), 1065-1073 (2004-06-08)
This study reports on the in vitro evaluation, biodistribution, and dosimetry of (123)I-labeled monoclonal antibody (mAb) 14C5, a new antibody-based agent proposed for radioimmunodetection of tumor growth and metastasis in vivo. (123)I-mAb 14C5 was prepared by direct iodination and tested
Mario De Decker et al.
Nuclear medicine and biology, 35(5), 599-604 (2008-07-01)
Alemtuzumab (Campath, Berlex) is a humanized IgG1 rat monoclonal antibody directed against the cell surface CD52 antigen, found on lymphocytes and monocytes. It is being developed for the treatment of chronic lymphocytic leukemia (CLL), autoimmune disease and for the prevention

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持